Bahram Valamehr - Mar 14, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Chief R&D Officer
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Mar 14, 2022
Transactions value $
-$708,483
Form type
4
Date filed
3/15/2022, 04:27 PM
Previous filing
Jan 27, 2022
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $68.3K +25K +13.9% $2.73 205K Mar 14, 2022 Direct F1
transaction FATE Common Stock Sale -$506K -16.7K -8.14% $30.36* 188K Mar 14, 2022 Direct F1, F2
transaction FATE Common Stock Sale -$97.1K -3.07K -1.63% $31.66* 185K Mar 14, 2022 Direct F1, F3
transaction FATE Common Stock Sale -$71.3K -2.2K -1.19% $32.49* 183K Mar 14, 2022 Direct F1, F4
transaction FATE Common Stock Sale -$98.6K -2.96K -1.62% $33.30* 180K Mar 14, 2022 Direct F1, F5
transaction FATE Common Stock Sale -$3.4K -100 -0.06% $34.04* 180K Mar 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -25K -40.88% $0.00 36.2K Mar 14, 2022 Common Stock 25K $2.73 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020.
F2 Represents the weighted average sale price of the shares sold from $30.00 to $30.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5.
F3 Represents the weighted average sale price of the shares sold from $31.00 to $31.99 per share.
F4 Represents the weighted average sale price of the shares sold from $32.00 to $32.99 per share.
F5 Represents the weighted average sale price of the shares sold from $33.00 to $33.91 per share.
F6 This option is fully vested.